DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery

NCT04462523 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

NETWORK

Sponsor class

Conditions

Vitreo-Retinal Surgery

Interventions

DRUG: Dextenza 0.4Mg Ophthalmic Insert
DRUG: Topical Prednisolone

Sponsor

Patrick R. Oellers, MD

Collaborators

[object Object]